v3.21.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 21,567,287 $ 10,931,890
Short-term investments 100,964,986 100,842,438
Accounts receivable 102,593 177,239
Prepaid expenses and other current assets 2,124,419 1,842,620
Total Current Assets 124,759,285 113,794,187
Property and Equipment, net 4,146,111 676,262
Other Assets    
In-process R&D 5,866,000 5,866,000
Goodwill 1,452,338 1,452,338
Grant receivable 368,465  
Operating lease right-of-use asset 1,857,309 2,035,882
Finance lease right-of-use asset 187,744 247,194
Deposits 152,267 122,779
Total Other Assets 9,884,123 9,724,193
Total Assets 138,789,519 124,194,642
Current Liabilities    
Accounts payable 1,180,965 1,051,764
Deferred revenue, current portion 603,717
Operating lease liability, current portion 293,226 278,753
Finance lease liability, current portion 111,411 108,127
Accrued expenses and other liabilities 1,766,311 1,614,534
Total Current Liabilities 3,351,913 3,656,895
Long Term Liabilities    
Other long-term liabilities 48,949 36,243
Derivative warrant liability 37,802 33,779
Deferred tax liability 361,911 361,911
Deferred revenue, net of current portion 237,500 237,500
Operating lease liability, net of current portion 1,151,886 1,301,636
Financing lease liability, net of current portion 103,700 160,240
Contingent consideration, net of current portion 2,336,626 2,250,844
Contingent consideration, related party - net of current portion 686,889 661,671
Total Liabilities 8,317,176 8,700,719
Commitments and Contingencies
Stockholders' Equity    
Common stock, $.0002 par value; 250,000,000 and 250,000,000 shares authorized, 25,137,502 and 22,592,500 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 5,027 4,519
Additional paid-in capital 276,225,048 247,048,349
Accumulated deficit (144,722,860) (130,647,485)
Accumulated other comprehensive loss (121,127) (166,056)
Total Stockholders' Equity - Heat Biologics, Inc. 131,386,088 116,239,327
Non-Controlling Interest (913,745) (745,404)
Total Stockholders' Equity 130,472,343 115,493,923
Total Liabilities and Stockholders' Equity $ 138,789,519 $ 124,194,642

Source